NeueHealth (NYSE:NEUE) Trading Up 1.3% - Still a Buy?

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) traded up 1.3% on Tuesday . The company traded as high as $6.65 and last traded at $6.58. 2,225 shares were traded during trading, a decline of 89% from the average session volume of 20,469 shares. The stock had previously closed at $6.49.

NeueHealth Stock Performance

The company has a fifty day simple moving average of $6.61 and a two-hundred day simple moving average of $6.22. The firm has a market capitalization of $54.48 million, a PE ratio of -0.13 and a beta of 0.54.

NeueHealth (NYSE:NEUE - Get Free Report) last released its quarterly earnings data on Thursday, March 20th. The company reported ($7.41) earnings per share for the quarter, missing analysts' consensus estimates of ($2.29) by ($5.12). The business had revenue of $232.64 million during the quarter, compared to analysts' expectations of $261.80 million. NeueHealth had a negative return on equity of 6.40% and a negative net margin of 36.28%. On average, equities analysts anticipate that NeueHealth, Inc. will post -9.13 earnings per share for the current fiscal year.

Insider Activity at NeueHealth

In related news, CEO George Lawrence Mikan III sold 13,180 shares of the firm's stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $6.93, for a total transaction of $91,337.40. Following the sale, the chief executive officer now owns 297,790 shares of the company's stock, valued at $2,063,684.70. This trade represents a 4.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jay Matushak sold 4,448 shares of NeueHealth stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $6.74, for a total value of $29,979.52. Following the completion of the transaction, the chief financial officer now owns 41,592 shares in the company, valued at $280,330.08. This trade represents a 9.66 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 68,178 shares of company stock valued at $467,763 over the last ninety days. 64.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On NeueHealth

An institutional investor recently bought a new position in NeueHealth stock. Virtu Financial LLC purchased a new position in shares of NeueHealth, Inc. (NYSE:NEUE - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 10,232 shares of the company's stock, valued at approximately $76,000. Virtu Financial LLC owned about 0.12% of NeueHealth as of its most recent filing with the Securities & Exchange Commission. 63.88% of the stock is owned by hedge funds and other institutional investors.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.